Skip to content

KORU MEDICAL SYSTEMS, INC.: 10-Q filed 2022-11-09

What KORU MEDICAL SYSTEMS, INC. reported in its quarterly report filed 2022-11-09 (fiscal Q3 2022): 46 published measures, 135 facts as tagged in accession 0001161697-22-000538.

This filing

Form
10-Q (quarterly report)
Filed
2022-11-09
Fiscal period
fiscal Q3 2022
Accession
0001161697-22-000538 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All KORU MEDICAL SYSTEMS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2022-09-3042,665,775USD
At 2021-12-3141,293,031USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2022-09-3010,174,050USD
At 2021-12-314,791,976USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2022-09-3032,491,725USD
At 2022-06-3032,621,350USD
At 2022-03-3134,801,097USD
At 2021-12-3136,501,055USD
At 2021-09-3036,798,241USD
At 2021-06-3037,263,742USD
At 2021-03-3137,783,119USD
At 2020-12-3136,156,979USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2022-09-3016,441,268USD
At 2021-12-3125,334,889USD
At 2021-09-3026,233,411USD
At 2020-12-3127,315,286USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2022-07-01 to 2022-09-30-1,225,560USD92
2022-01-01 to 2022-09-30-6,684,415USD273
2022-04-01 to 2022-06-30-2,921,341USD91
2022-01-01 to 2022-03-31-2,537,514USD90
2021-07-01 to 2021-09-30-1,093,778USD92
2021-01-01 to 2021-09-30-3,494,465USD273
2021-04-01 to 2021-06-30-1,124,549USD91
2021-01-01 to 2021-03-31-1,276,138USD90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2022-01-01 to 2022-09-30-6,741,013USD273
2021-01-01 to 2021-09-30-3,602,378USD273

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2022-07-01 to 2022-09-307,760,398USD92
2022-01-01 to 2022-09-3020,551,356USD273
2021-07-01 to 2021-09-306,040,544USD92
2021-01-01 to 2021-09-3016,999,669USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2022-01-01 to 2022-09-30425,088USD273
2021-01-01 to 2021-09-302,838,996USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2022-01-01 to 2022-09-30-2,577,696USD273
2021-01-01 to 2021-09-30-318,493USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2022-09-30-7,594,484USD
At 2021-12-31-910,069USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2022-07-01 to 2022-09-3045,038,181shares92
2022-01-01 to 2022-09-3044,877,366shares273
2021-07-01 to 2021-09-3044,322,335shares92
2021-01-01 to 2021-09-3044,510,021shares273

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2022-07-01 to 2022-09-3045,038,181shares92
2022-01-01 to 2022-09-3044,877,366shares273
2021-07-01 to 2021-09-3044,322,335shares92
2021-01-01 to 2021-09-3044,510,021shares273

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2022-07-01 to 2022-09-30-0.03USD/shares92
2022-01-01 to 2022-09-30-0.15USD/shares273
2021-07-01 to 2021-09-30-0.02USD/shares92
2021-01-01 to 2021-09-30-0.08USD/shares273

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2022-07-01 to 2022-09-30-0.03USD/shares92
2022-01-01 to 2022-09-30-0.15USD/shares273
2021-07-01 to 2021-09-30-0.02USD/shares92
2021-01-01 to 2021-09-30-0.08USD/shares273

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2022-07-01 to 2022-09-30-271,500USD92
2022-01-01 to 2022-09-30-1,579,359USD273
2021-07-01 to 2021-09-30-238,104USD92
2021-01-01 to 2021-09-30-1,425,781USD273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2022-09-303,318,612USD
At 2021-12-311,106,445USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2022-01-01 to 2022-09-302,361,085USD273
2021-01-01 to 2021-09-301,967,632USD273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2022-07-01 to 2022-09-30-1,529,479USD92
2022-01-01 to 2022-09-30-8,269,456USD273
2021-07-01 to 2021-09-30-1,322,034USD92
2021-01-01 to 2021-09-30-4,916,377USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2022-09-3030,742,264USD
At 2021-12-3137,321,154USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2022-09-306,167,493USD
At 2021-12-314,791,976USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2022-09-301,365,610USD
At 2021-12-311,227,533USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2022-09-30798,534USD
At 2021-12-31808,813USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2022-09-305,070,077USD
At 2021-12-313,592,886USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2022-07-01 to 2022-09-305,851,841USD92
2022-01-01 to 2022-09-3019,560,296USD273
2021-07-01 to 2021-09-304,817,784USD92
2021-01-01 to 2021-09-3014,854,165USD273

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2022-09-306,884,156USD
At 2021-12-316,106,338USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2022-07-01 to 2022-09-304,322,362USD92
2022-01-01 to 2022-09-3011,290,840USD273
2021-07-01 to 2021-09-303,495,750USD92
2021-01-01 to 2021-09-309,937,788USD273

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2022-07-01 to 2022-09-304,825,349USD92
2022-01-01 to 2022-09-3015,846,584USD273
2021-07-01 to 2021-09-303,901,830USD92
2021-01-01 to 2021-09-3012,980,604USD273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2022-07-01 to 2022-09-30862,148USD92
2022-01-01 to 2022-09-303,314,233USD273
2021-07-01 to 2021-09-30800,020USD92
2021-01-01 to 2021-09-301,523,739USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2022-09-3045,236,521shares
At 2021-12-3144,623,660shares

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2022-09-303,865,370USD
At 2021-12-3195,553USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2022-09-304,083,414USD
At 2021-12-3195,553USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2022-09-305,945,585USD
At 2021-12-313,418,479USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2022-09-302,626,973USD
At 2021-12-312,312,034USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2022-09-3088,772USD
At 2021-12-3119,812USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2022-09-302,568,746USD
At 2021-12-312,709,704USD

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2022-07-01 to 2022-09-30130,882USD92
2022-01-01 to 2022-09-30329,526USD273
2021-07-01 to 2021-09-30100,502USD92
2021-01-01 to 2021-09-30301,469USD273

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2022-07-01 to 2022-09-30164,344USD92
2022-01-01 to 2022-09-30399,479USD273
2021-07-01 to 2021-09-30115,934USD92
2021-01-01 to 2021-09-30349,822USD273

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2022-07-01 to 2022-09-3042,476USD92
2022-01-01 to 2022-09-3044,579USD273
2021-07-01 to 2021-09-30-2,838USD92
2021-01-01 to 2021-09-3016,883USD273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2022-07-01 to 2022-09-3032,419USD92
2022-01-01 to 2022-09-305,682USD273
2021-07-01 to 2021-09-30-9,848USD92
2021-01-01 to 2021-09-30-3,869USD273

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2022-01-01 to 2022-09-3015,700USD273
2021-01-01 to 2021-09-306,194USD273

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2021-01-01 to 2021-09-30850USD273

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2022-01-01 to 2022-09-30314,000USD273
2021-01-01 to 2021-09-301,230,000USD273

Operating lease payments

Cash paid for operating lease liabilities during the period. It differs from lease expense recognized and excludes variable payments in some presentations.

PeriodValueUnitDays
2022-01-01 to 2022-09-30301,150USD273
2021-01-01 to 2021-09-30105,618USD273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2022-01-01 to 2022-09-301,445,079USD273
2021-01-01 to 2021-09-30549,711USD273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2022-01-01 to 2022-09-30777,818USD273
2021-01-01 to 2021-09-30138,160USD273

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2022-01-01 to 2022-09-30138,077USD273
2021-01-01 to 2021-09-30760,493USD273

Inspect the source

Entity
KORU MEDICAL SYSTEMS, INC. / CIK 0000704440
Captured
SEC response SHA-256
b53967f6fe0da17327c3bbc894c28ecf420f6c43e7707a871a63a9c303887166

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000704440.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))